Successful completion of USFDA inspection at Alembic Pharma Oral Solid Formulation Facility (F-I) at Panelav

Read more

Phase III post-marketing commitment study data paves way for usage of Paratek’s Nuzyra in other indications: GlobalData

Read more

US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug

Read more

Navigating the IPR maze: India’s pharmaceutical challenge

Read more

Revolutionising cancer treatment: The promise of point-of-care CAR-T therapy

Read more

Emcure signs PPA with Sunsure Energy for solar power

Read more

Cohance, Suven merger get approval from NSE and BSE

Read more

NutrifyGenie AI: Pioneering the future of AI-driven nutraceutical innovation

Read more

NovaLead’s patented repurposed drug gets CDSCO nod for DFU patients in India

Read more

Eisai selects Medidata’s Clinical Data Studio to enhance clinical trial efficiency

Read more